Pipeline

OSR Holdings, an Open and Socially Responsible Healthcare Group

Immunotherapy · Vaximm

VXM01

Glioblastoma
  • Preclinical

  • Phase 1

  • Phase 2

  • Phase 3

  • Review

  • Commercialization

Immunotherapy · Vaximm

VXM04

Mesothelin
  • Preclinical

  • Phase 1

  • Phase 2

  • Phase 3

  • Review

  • Commercialization

Immunotherapy · Vaximm

VXM06

WT1
  • Preclinical

  • Phase 1

  • Phase 2

  • Phase 3

  • Review

  • Commercialization

Immunotherapy · Vaximm

VXM08

CEA
  • Preclinical

  • Phase 1

  • Phase 2

  • Phase 3

  • Review

  • Commercialization

Immunotherapy · Vaximm

VXM10

PD-L1
  • Preclinical

  • Phase 1

  • Phase 2

  • Phase 3

  • Review

  • Commercialization

Biobetter · Darnatein

DRT102-sp

Lumbar stenosis
  • Concept

  • Planning

  • Design

  • Validation

  • Review

  • Commercialization

Biobetter · Darnatein

DRT102-sp

Disc herniation
  • Concept

  • Planning

  • Design

  • Validation

  • Review

  • Commercialization

Biobetter · Darnatein

DRT102-sp

Spinal
  • Concept

  • Planning

  • Design

  • Validation

  • Review

  • Commercialization

Biobetter · Darnatein

DRT102-dt

Dental Augmentation
  • Concept

  • Planning

  • Design

  • Validation

  • Review

  • Commercialization

Biobetter · Darnatein

DRT102-nu

Non-union bone fracture
  • Concept

  • Planning

  • Design

  • Validation

  • Review

  • Commercialization

Biobetter · Darnatein

DRT101

Osteoarthritis
  • Preclinical

  • Phase 1

  • Phase 2

  • Phase 3

  • Review

  • Commercialization

Medical Device · RMC

Asahi Intecc

Neurivascular GuideWire
  • Concept

  • Planning

  • Design

  • Validation

  • Review

  • Commercialization

Medical Device · RMC

Penumbra

Reperfusion Catheter
  • Concept

  • Planning

  • Design

  • Validation

  • Review

  • Commercialization

Medical Device · RMC

Rapid Medical

Aneurysm
  • Concept

  • Planning

  • Design

  • Validation

  • Review

  • Commercialization

검색 닫기